These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29525403)

  • 1. The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis.
    Hou W; Wei P; Xie J; Zheng Y; Zhang Y; Zhou X
    Pathol Res Pract; 2018 Apr; 214(4):513-520. PubMed ID: 29525403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients.
    Schrader C; Meusers P; Brittinger G; Janssen D; Teymoortash A; Siebmann JU; Parwaresch R; Tiemann M
    Virchows Arch; 2006 Feb; 448(2):151-9. PubMed ID: 16133361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein.
    Shiozawa E; Yamochi-Onizuka T; Yamochi T; Yamamoto Y; Naitoh H; Kawakami K; Nakamaki T; Tomoyasu S; Kushima M; Ota H
    Pathol Res Pract; 2003; 199(5):293-302. PubMed ID: 12908519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent immunohistochemical expression of CD21 and CD23 by follicular dendritic cells with increasing grade of follicular lymphoma.
    Kurshumliu F; Sadiku-Zehri F; Qerimi A; Vela Z; Jashari F; Bytyci S; Rashiti V; Sadiku S
    World J Surg Oncol; 2019 Jul; 17(1):115. PubMed ID: 31269981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
    Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
    Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China.
    He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z
    Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
    Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database.
    Salek D; Vesela P; Boudova L; Janikova A; Klener P; Vokurka S; Jankovska M; Pytlik R; Belada D; Pirnos J; Moulis M; Kodet R; Michal M; Janousova E; Muzik J; Mayer J; Trněný M
    Leuk Lymphoma; 2014 Apr; 55(4):802-10. PubMed ID: 23772666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma.
    Blaker YN; Brodtkorb M; Maddison J; Hveem TS; Nesheim JA; Mohn HM; Kolstad A; Geisler CH; Liestøl K; Smeland EB; Holte H; Delabie J; Danielsen H
    Histopathology; 2015 Jul; 67(1):62-9. PubMed ID: 25431344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
    Goy A; Kalayoglu Besisik S; Drach J; Ramchandren R; Robertson MJ; Avivi I; Rowe JM; Herbrecht R; Van Hoof A; Zhang L; Cicero S; Fu T; Witzig T
    Br J Haematol; 2015 Aug; 170(4):496-503. PubMed ID: 25921098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
    Jin MK; Hoster E; Dreyling M; Unterhalt M; Hiddemann W; Klapper W
    Histopathology; 2011 Mar; 58(4):586-92. PubMed ID: 21401698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular dendritic cell pattern in early lymphomas involving follicles.
    Carbone A; Gloghini A
    Adv Anat Pathol; 2014 Jul; 21(4):260-9. PubMed ID: 24911251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
    Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
    Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.